PRESS RELEASE published on 02/11/2026 at 15:02, 7 months 7 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses 5.03% ownership in Beazley plc as of 10-Feb-2026 Relevant Securities The Vanguard Group Ownership Disclosure Financial Disclosure Beazley Plc
BRIEF published on 02/11/2026 at 15:01, 7 months 7 days ago Vanguard Discloses Position in NCC Group plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group NCC Group Plc
PRESS RELEASE published on 02/11/2026 at 14:59, 7 months 7 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses 3.60% stake in Spire Healthcare Group plc. Public disclosure under Rule 8.3 of the Takeover Code on 11 Feb 2026 Rule 8.3 Vanguard Group Inc. Takeover Code Stake Disclosure Spire Healthcare Group Plc
PRESS RELEASE published on 02/11/2026 at 14:58, 7 months 7 days ago Form 8.3 - The Vanguard Group, Inc.: Just Group plc The Vanguard Group, Inc. discloses 4.93% ownership in Just Group plc in a Form 8.3 filing. Public position disclosure under Rule 8.3 of the Takeover Code Form 8.3 Takeover Code Vanguard Group Ownership Disclosure Just Group Plc
PRESS RELEASE published on 02/11/2026 at 14:57, 7 months 7 days ago Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited The Vanguard Group, Inc. files Form 8.3 for Picton Property Income Limited disclosing 5.25% ownership of relevant securities. No other party disclosures made Securities Form 8.3 Vanguard Group Ownership Disclosure Picton Property Income Limited
PRESS RELEASE published on 02/11/2026 at 14:56, 7 months 7 days ago Form 8.3 - The Vanguard Group, Inc.: NCC Group plc The Vanguard Group, Inc. discloses 4.72% ownership in 1p ordinary shares of NCC Group plc as of 10 Feb 2026 Disclosure The Vanguard Group Ownership 1p Ordinary Shares NCC Group Plc
BRIEF published on 02/10/2026 at 15:14, 7 months 8 days ago Vanguard Group Discloses Stake in JTC plc Takeover Code Vanguard Group Shareholding Stake Disclosure JTC Plc
BRIEF published on 02/10/2026 at 15:14, 7 months 8 days ago The Vanguard Group's Position on Avadel Pharmaceuticals plc Form 8.3 Securities Disclosure Vanguard Group Takeover Rules Avadel Pharmaceuticals
BRIEF published on 02/10/2026 at 15:13, 7 months 8 days ago Vanguard Group Discloses Stake in Beazley plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group Beazley Plc
BRIEF published on 02/10/2026 at 15:12, 7 months 8 days ago The Vanguard Group's Position in Spire Healthcare Group plc Disclosure Takeover Code Vanguard Group Spire Healthcare Stock Acquisition
Published on 09/18/2026 at 14:30, 1 hour 19 minutes ago AIAI Holdings to Obtain a Controlling Position in Messier 42 Marketing Agreement
Published on 09/18/2026 at 13:30, 2 hours 19 minutes ago Alset AI Provides Shareholder Update, Announces Updated Investor Presentation and Appoints Mitchell Jackman as Chief Financial Officer
Published on 09/18/2026 at 06:30, 9 hours 19 minutes ago GREE Chairperson Dong Mingzhu Honored by UNEP Cool Coalition for Leadership in Sustainable Cooling
Published on 09/18/2026 at 00:55, 14 hours 54 minutes ago Tectonic Metals Announces Results of the 2026 Annual General Meeting
Published on 09/18/2026 at 14:25, 1 hour 24 minutes ago Huawei Unveils Innovative Immersive Telepresence Solution That Offers Immersive Experiences and Intelligent Services
Published on 09/18/2026 at 13:52, 1 hour 57 minutes ago New rules for green claims. Does eco-friendly also mean animal-friendly?
Published on 09/18/2026 at 13:51, 1 hour 57 minutes ago Completion of the Acquisition of a Majority Stake in Jucari Global Pty Ltd
Published on 09/17/2026 at 17:40, 22 hours 9 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 22 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 2 days 8 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
